ResMed Inc.
RSMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $37,853 | $27,484 | $32,068 | $30,620 |
| - Cash | $1,209 | $238 | $228 | $274 |
| + Debt | $852 | $874 | $1,580 | $918 |
| Enterprise Value | $37,495 | $28,120 | $33,420 | $31,264 |
| Revenue | $5,146 | $4,685 | $4,223 | $3,578 |
| % Growth | 9.8% | 10.9% | 18% | – |
| Gross Profit | $3,055 | $2,655 | $2,356 | $2,024 |
| % Margin | 59.4% | 56.7% | 55.8% | 56.6% |
| EBITDA | $1,913 | $1,534 | $1,359 | $1,177 |
| % Margin | 37.2% | 32.7% | 32.2% | 32.9% |
| Net Income | $1,401 | $1,021 | $898 | $779 |
| % Margin | 27.2% | 21.8% | 21.3% | 21.8% |
| EPS Diluted | 9.51 | 6.92 | 6.09 | 5.3 |
| % Growth | 37.4% | 13.6% | 14.9% | – |
| Operating Cash Flow | $1,752 | $1,401 | $693 | $351 |
| Capital Expenditures | -$90 | -$115 | -$134 | -$156 |
| Free Cash Flow | $1,662 | $1,286 | $559 | $195 |